Tune in to this must listen episode with Professor Shankar Siva from the Peter MacCallum Cancer Centre. We revisit the role of radiotherapy in renal cell cancers, focusing on stereotactic radiotherapy.

We discuss the set up of a phase III clinical trial , the importance of collaboration and patient involvement as well as clinically relevant endpoints, patient reported-outcomes and health economics.